DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways
- PMID: 30569110
- DOI: 10.3892/ijo.2018.4667
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways
Abstract
Dickkopf‑related protein 3 (DKK3), which is a member of the Dickkopf WNT signaling pathway inhibitor family, is considered to be a tumor suppressor, due to its reduced expression in cancer cells and its ability to induce apoptosis when overexpressed by adenovirus. However, our previous study demonstrated alternative functions for DKK3 in head and neck squamous cell carcinoma (HNSCC). Our study reported that DKK3 expression was predominantly upregulated in HNSCC cell lines and tissue samples, and its expression was significantly correlated with poor prognosis. Furthermore, DKK3 overexpression in HNSCC cells significantly increased cancer cell proliferation, migration, invasion and in vivo tumor growth. These data have led to the hypothesis that DKK3 may exert oncogenic functions and may increase the malignant properties of HNSCC. The present study established a stable DKK3 knockdown cell line (HSC‑3 shDKK3) using lentivirus‑mediated short hairpin RNA, and assessed its effects on cancer cell behavior using MTT, migration and invasion assays. In addition, its effects on in vivo tumor growth were assessed using a xenograft model. Furthermore, the molecular mechanisms underlying the effects of DKK3 knockdown were investigated by microarray analysis, pathway analysis and western blotting. Compared with control cells, HSC‑3 shDKK3 cells exhibited significantly reduced proliferation, migration and invasion, and formed significantly smaller tumor masses when subcutaneously transplanted into nude mice. In addition, in HSC‑3 shDKK3 cells, the expression levels of phosphorylated (p)‑protein kinase B (Akt) (Ser473), p‑phosphoinositide 3‑kinase (PI3K) p85 (Tyr467), p‑PI3K p55 (Try199), p‑3‑phosphoinositide‑dependent protein kinase‑1 (PDK1) (Ser241) and total p38 mitogen‑activated protein kinase (MAPK) were reduced. Furthermore, phosphorylation of mechanistic target of rapamycin (mTOR) (Ser2448) was slightly decreased in HSC‑3 shDKK3 cells, which may be due to the increased expression of DEP domain‑containing mTOR‑interacting protein. Conversely, DKK3 overexpression in HSC‑3 shDKK3 cells rescued cellular proliferation, migration and invasion. With regards to expression levels, p‑PI3K and p‑PDK1 expression was not altered, whereas mTOR and p‑p38 MAPK expression was elevated. These data supported the hypothesis and indicated that DKK3 may contribute to the malignant phenotype of HNSCC cells via the PI3K/Akt/mTOR and MAPK signaling pathways.
Keywords: head and neck squamous cell carcinoma; Dickkopfrelated protein 3; phosphoinositide 3-kinase; protein kinase B; mitogen-activated protein kinase.
Similar articles
-
DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.Oncol Res. 2018 Jan 19;26(1):45-58. doi: 10.3727/096504017X14926874596386. Epub 2017 May 4. Oncol Res. 2018. PMID: 28470144 Free PMC article.
-
G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.Comput Math Methods Med. 2022 Jan 25;2022:6881932. doi: 10.1155/2022/6881932. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Nov 1;2023:9792473. doi: 10.1155/2023/9792473. PMID: 35116073 Free PMC article. Retracted.
-
IGF2BP1 promotes the progression of head and neck squamous cell carcinoma by activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.World J Surg Oncol. 2025 Jul 14;23(1):277. doi: 10.1186/s12957-025-03929-5. World J Surg Oncol. 2025. PMID: 40660234 Free PMC article.
-
DKK3 expression and function in head and neck squamous cell carcinoma and other cancers.J Oral Biosci. 2020 Mar;62(1):9-15. doi: 10.1016/j.job.2020.01.008. Epub 2020 Feb 4. J Oral Biosci. 2020. PMID: 32032750 Review.
-
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.Expert Opin Ther Targets. 2015 Jun;19(6):795-805. doi: 10.1517/14728222.2015.1012157. Epub 2015 Feb 5. Expert Opin Ther Targets. 2015. PMID: 25652792 Review.
Cited by
-
MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.Cancers (Basel). 2022 Sep 23;14(19):4625. doi: 10.3390/cancers14194625. Cancers (Basel). 2022. PMID: 36230547 Free PMC article. Review.
-
The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages.Oral Oncol. 2020 Apr;103:104591. doi: 10.1016/j.oraloncology.2020.104591. Epub 2020 Feb 10. Oral Oncol. 2020. PMID: 32058294 Free PMC article. Review.
-
Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma.Front Oncol. 2022 Apr 14;12:862751. doi: 10.3389/fonc.2022.862751. eCollection 2022. Front Oncol. 2022. PMID: 35494000 Free PMC article.
-
Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway.Front Oncol. 2022 Feb 1;12:833719. doi: 10.3389/fonc.2022.833719. eCollection 2022. Front Oncol. 2022. PMID: 35178352 Free PMC article.
-
Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).Cancer Cell Int. 2022 Nov 15;22(1):352. doi: 10.1186/s12935-022-02783-9. Cancer Cell Int. 2022. PMID: 36376957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous